Spinal Cord Stimulation in Hypotensive Heart Failure Patients: Hemodynamic Assessment
Stopped: No perceivable effect of transcutaneous spinal cord stimulation on blood pressure in heart failure patients
Russia6 participantsStarted 2022-03-25
Plain-language summary
This is a prospective single-center study that aims to evaluate the effects of non-invasive transcutaneous spinal cord stimulation on systemic and pulmonary hemodynamics, assessed during right heart catheterization in patients with heart failure and persistent or transient hypotension subjected to be included into the heart transplantation waiting list.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 18-75 years.
✓. Patients with heart failure III-IV functional class (NYHA) with indications to right heart catheterization.
✓. Systolic blood pressure \<110/70 mm Hg when measured while sitting.
✓. Patient who signed an informed consent form.
Exclusion criteria
✕. Hypovolemic status (central venous pressure \<2 mm Hg).
✕. Any acute illness.
✕. Transient ischemic event or stroke within 2 weeks prior to inclusion.
✕. Pulmonary embolism \<1 month ago.
✕. Epilepsy.
✕. An implanted infusion pump.
✕. Pacemaker-dependent patients.
What they're measuring
1
Systolic blood pressure elevation
Timeframe: 10 minutes
Trial details
NCT IDNCT05288387
SponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health